Publication | Closed Access

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Metastatic Breast CancerOncologyBreast OncologyCancer ManagementClinical TrialsBreast CancerCancer TreatmentMedicineRadiation OncologyPhase 3Health Sciences